The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH 2019 | Sagar Lonial discusses his top myeloma research picks
Sagar Lonial
• 1 Apr 2019
Sagar Lonial, MD, FACP, Emory University, Atlanta, GA, discusses key pieces of research in the multiple myeloma field such as the optimization of induction therapy and the CAR T-cell therapy revolution. This interview took place at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.
